Search research articles
Contact Us
Filters
Showing results (71-80 of 164) with videos related to
Page
of 17
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
April 28, 2019
DNA damage in blood leucocytes of prostate cancer patients during therapy with <sup>177</sup>Lu-PSMA
Sarah Schumann, Harry Scherthan, Constantin Lapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 12, 2013
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases
Heribert Hänscheid, Cristina Canzi, Wolfgang Eschner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2020
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
Mark Konijnenberg, Ken Herrmann, Carsten Kobe, et al.
Current Radiopharmaceuticals
|
December 22, 2012
Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphoma
Ada H V Repetto-Llamazares, Roy H Larsen, Camilla Mollatt, et al.
Contrast Media & Molecular Imaging
|
February 9, 2019
In Vivo Biokinetics of <sup>177</sup>Lu-OPS201 in Mice and Pigs as a Model for Predicting Human Dosimetry
Seval Beykan, Melpomeni Fani, Svend Borup Jensen, et al.
Zeitschrift Fur Medizinische Physik
|
March 23, 2026
DNA damage induction and repair in peripheral blood mononuclear cells induced by internal ex vivo irradiation with β- and γ-emitting radionuclides
Sarah Schumann, Isabella Strobel, Johanna Hahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2007
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"
Glenn Flux, Manuel Bardies, Carlo Chiesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 18, 2017
The "reset button" revisited: why high activity <sup>131</sup>I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
Frederik A Verburg, Markus Luster, Luca Giovanella, et al.
Zeitschrift Fur Medizinische Physik
|
September 4, 2023
PSMA-PET improves deep learning-based automated CT kidney segmentation
Julian Leube, Matthias Horn, Philipp E Hartrampf, et al.
Plos One
|
September 10, 2013
Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?
Veronika Preylowski, Susanne Schlögl, Frédéric Schoenahl, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 164) with videos related to
Sort By:
Page
of 17
European Journal of Nuclear Medicine and Molecular Imaging
|
April 28, 2019
DNA damage in blood leucocytes of prostate cancer patients during therapy with <sup>177</sup>Lu-PSMA
Sarah Schumann, Harry Scherthan, Constantin Lapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 12, 2013
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases
Heribert Hänscheid, Cristina Canzi, Wolfgang Eschner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2020
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
Mark Konijnenberg, Ken Herrmann, Carsten Kobe, et al.
Current Radiopharmaceuticals
|
December 22, 2012
Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphoma
Ada H V Repetto-Llamazares, Roy H Larsen, Camilla Mollatt, et al.
Contrast Media & Molecular Imaging
|
February 9, 2019
In Vivo Biokinetics of <sup>177</sup>Lu-OPS201 in Mice and Pigs as a Model for Predicting Human Dosimetry
Seval Beykan, Melpomeni Fani, Svend Borup Jensen, et al.
Zeitschrift Fur Medizinische Physik
|
March 23, 2026
DNA damage induction and repair in peripheral blood mononuclear cells induced by internal ex vivo irradiation with β- and γ-emitting radionuclides
Sarah Schumann, Isabella Strobel, Johanna Hahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2007
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"
Glenn Flux, Manuel Bardies, Carlo Chiesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 18, 2017
The "reset button" revisited: why high activity <sup>131</sup>I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
Frederik A Verburg, Markus Luster, Luca Giovanella, et al.
Zeitschrift Fur Medizinische Physik
|
September 4, 2023
PSMA-PET improves deep learning-based automated CT kidney segmentation
Julian Leube, Matthias Horn, Philipp E Hartrampf, et al.
Plos One
|
September 10, 2013
Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?
Veronika Preylowski, Susanne Schlögl, Frédéric Schoenahl, et al.
Page
of 17